NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market. To ...

Telangana DCA seizes spurious ‘Levipil 500’ falsely labelled as Sun Pharma product: Our Bureau, Chennai Tuesday, January 13, 2026, 15:30 Hrs [IST] The Drugs Control Administra ...

Wilmington PharmaTech ("WPT"), a U.S.-based specialty contract research, development and manufacturing organization (CRDMO) focused on complex custom small molecule API, today announced that it has ...

Mandara Biopharma Inc., a privately held U.S.-based biopharmaceutical company focused on novel therapies for central nervous system (CNS) disorders, today announced that it has filed an ...

Bionpharma gets US FDA nod for etravirine tablets developed in collaboration with STEERLife: Our Bureau, Bengaluru Tuesday, January 13, 2026, 16:15 Hrs [IST] Bionpharma Inc. has a ...

State-of-the-art pharmaceutical manufacturing facility creates 250 jobs, strengthens India’s nutraceutical and cosmeceutical ...

Investec says Rubicon’s R&D, capital allocation and acquisition strategy has created a ROI-led growth engine across its ...

IDEXX Laboratories, Inc. , a global leader in pet healthcare innovation, today announced the promotion of Michael (Mike) Erickson, PhD, to President and Chief Executive Officer, effective May 12, 2026 ...

According to industry bodies, the government should consider offering globally competitive R&D incentives and fiscal support ...

Altoida, Inc., a pioneer in AI- and AR-powered digital diagnostics for neurological diseases, today announced a research collaboration with Mindspan, the cognitive care company focused on changing the ...

VSee's Rapidly Configurable AI Telehealth Platform Addresses Rural Hospital Access and Financial Sustainability SAN JOSE, CALIFORNIA / ACCESS Newswire / January 12, 2026 / VSee Health, Inc.